Vaxcyte Inc annual earnings per share (EPS) for fiscal TTM was $-7.64, a decrease of 35.7% from $-5.63 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-7.64 | $-5.63 | $-3.80 | $-4.14 | $-3.44 | $-1.93 | $-3.02 | $-1.03 | $-1.15 | $-4.83 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-1.97 | $-2.30 | $-1.81 | $-1.56 | $-1.22 | $-1.04 | $-1.12 | $-0.83 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More PCVX metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All PCVX financial statements → Interactive PCVX charts →
About TickerBase · Data methodology & sources · Privacy · Terms